Message Font: Serif | Sans-Serif
No. of Recommendations: 0
NORCROSS, Ga., Aug. 17 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has signed a supply agreement with the American Red Cross for 19 Galileo systems for its five U.S. National Testing Laboratories.
"The American Red Cross is one of the largest and most prestigious health care organizations in the United States and these five laboratories test approximately seven million units of blood annually," said Dr. Gioacchino De Chirico, President and CEO of Immucor. "We are very pleased the American Red Cross has chosen the Galileo system for its laboratories. We expect these instruments to generate a total of at least $5 million a year in new reagent revenue after they are all live, depending on the amount and type of testing done on each instrument."
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.